Document is current
Any future updates will be listed below
-
Authors
Kim, Enji https://orcid.org/0000-0002-4934-8951
Jeong, Eunseon https://orcid.org/0000-0003-0513-8693
Hong, Yeon-Mi
Jeong, Inhea https://orcid.org/0000-0003-2226-4755
Kim, Junghoon
Kwon, Yong Won
Park, Young-Geun https://orcid.org/0000-0003-1579-0220
Lee, Jiin
Choi, Suah
Kim, Ju-Young https://orcid.org/0000-0001-5807-7017
Lee, Jae-Hyun https://orcid.org/0000-0002-9236-157X
Cho, Seung-Woo https://orcid.org/0000-0001-8058-332X
Park, Jang-Ung https://orcid.org/0000-0003-1522-4958
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (RS-2024-00460364, RS-2024-00406240)
- License Information
-
More Information
Article History
Received: 4 January 2024
Accepted: 23 December 2024
First Online: 27 February 2025
Competing interests
: S.-W.C. is a chief technology officer (CTO) of Cellartgen, Inc., Republic of Korea. The remaining authors declare no competing interests.
